Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma

被引:195
|
作者
Imamurai, H
Marsuyama, Y
Miyagawa, Y
Ishida, K
Shimada, R
Miyagawa, S
Makuuchi, M
Kawasaki, S
机构
[1] Univ Tokyo, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Sch Hlth Sci & Nursing, Dept Biostat, Tokyo 1138655, Japan
[3] Shinshu Univ, Sch Med, Dept Surg 1, Nagano, Japan
关键词
D O I
10.1046/j.1365-2168.1999.01185.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Portal venous tumour extension and intrahepatic metastasis result in a poor prognosis following hepatectomy for hepatocellular carcinoma (HCC). Anatomical resection is, in theory, preferable for eradicating these types of invasion. Des-gamma-carboxy prothrombin (DCP) has been reported to be associated with adverse pathological variables. This study investigated the significance of anatomical resection and DCP as predictive factors for postoperative recurrence of HCC. Methods: A retrospective cohort study was carried out in 138 consecutive patients who underwent hepatectomy for RCC smaller than 5 cm using the Cox proportional hazards model. Results: Eight factors were univariately related to poor prognosis (in decreasing order of hazard ratio): intrahepatic metastasis, multiple tumours, a-fetoprotein 32ng/ml or more; DCP greater than 0.1 arbitrary units (AU), tumour-exposed surgical margin, vascular invasion, non-anatomical resection and tumour 2.5 cm or more. Three variables (DCP, vascular invasion and tumour-exposed surgical margin) mere excluded by a stepwise procedure in multivariate analysis. Although DCP was not an independent prognostic factor, a model replacing intrahepatic metastasis with DCP showed similar predictive accuracy in a receiver-operating characteristic curve. Conclusion: Anatomical resection appeared to have a beneficial effect on recurrence-free survival after hepatectomy for RCC. DCP measurement was effective in predicting HCC recurrence and had the advantage that it can be assessed before operation.
引用
收藏
页码:1032 / 1038
页数:7
相关论文
共 50 条
  • [41] Clinical significance of half-lives of tumor markers α-fetoprotein and des-γ-carboxy prothrombin after hepatectomy for hepatocellular carcinoma
    Tsukamoto, Masayo
    Nitta, Hidetoshi
    Imai, Katsunori
    Higashi, Takaaki
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Arima, Kota
    Kaida, Takayoshi
    Taki, Katsunobu
    Hashimoto, Daisuke
    Chikamoto, Akira
    Ishiko, Takatoshi
    Beppu, Toru
    Baba, Hideo
    HEPATOLOGY RESEARCH, 2018, 48 (03) : E183 - E193
  • [42] Significance of Des-gamma-carboxy Prothrombin Production in Hepatocellular Carcinoma
    Fujikawa, Tatsuya
    Shiraha, Hidenori
    Yamamoto, Kazuhide
    ACTA MEDICA OKAYAMA, 2009, 63 (06) : 299 - 304
  • [43] Clinicopathological features of hepatocellular carcinoma seropositive for α-fetoprotein and those seropositive for des-γ-carboxy prothrombin.
    Okuda, H
    Nakanishi, T
    Takatsu, K
    Saito, A
    Hayashi, N
    Takenami, K
    Yamamoto, M
    Takasaki, K
    Nakano, M
    HEPATOLOGY, 1999, 30 (04) : 684A - 684A
  • [44] Diagnostic performance of Des-γ-carboxy prothrombin (DCP) for Hepatocellular carcinoma: A Bivariate Meta-analysis
    Gao, P.
    Li, M.
    Tian, Q. B.
    Liu, D. W.
    NEOPLASMA, 2012, 59 (02) : 150 - 159
  • [45] Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
    Kenichi Hakamada
    Norihisa Kimura
    Takuya Miura
    Hajime Morohashi
    Keinosuke Ishido
    Masaki Nara
    Yoshikazu Toyoki
    Shunji Narumi
    Mutsuo Sasaki
    World Journal of Gastroenterology, 2008, (09) : 1370 - 1377
  • [46] Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
    Hakamada, Kenichi
    Kimura, Norihisa
    Miura, Takuya
    Morohashi, Hajime
    Ishido, Keinosuke
    Nara, Masaki
    Toyoki, Yoshikazu
    Narumi, Shunji
    Sasaki, Mutsuo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (09) : 1370 - 1377
  • [47] The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma Patients
    Yamamoto, Shumpei
    Onishi, Hideki
    Takaki, Akinobu
    Oyama, Atsushi
    Adachi, Takuya
    Wada, Nozomu
    Sakata, Masahiro
    Yasunaka, Tetsuya
    Shiraha, Hidenori
    Okada, Hiroyuki
    GASTROINTESTINAL TUMORS, 2020, 7 (03) : 83 - 92
  • [48] Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-γ-carboxy prothrombin:: a prospective study
    Ikoma, J
    Kaito, M
    Ishihara, T
    Nakagawa, N
    Kamei, A
    Fujita, N
    Iwasa, M
    Tamaki, S
    Watanabe, S
    Adachi, Y
    HEPATO-GASTROENTEROLOGY, 2002, 49 (43) : 235 - 238
  • [49] Diagnostic accuracy of a-fetoprotein and des-?-carboxy prothrombin in screening for hepatocellular carcinoma in liver transplant candidates
    Yamashiki, Noriyo
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Yoshida, Haruhiko
    Aoki, Taku
    Hasegawa, Kiyoshi
    Akahane, Masaaki
    Ohtomo, Kuni
    Fukayama, Masashi
    Koike, Kazuhiko
    Kokudo, Norihiro
    HEPATOLOGY RESEARCH, 2011, 41 (12) : 1199 - 1207
  • [50] Clinical Utility of Des-γ-Carboxy Prothrombin Kinetics as a Complement to Radiologic Response in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Park, Won-Hyeong
    Shim, Ju-Hyun
    Han, Seung-Bong
    Won, Hyung-Jin
    Shin, Yong-Moon
    Kim, Kang-Mo
    Lim, Young-Suk
    Lee, Han-Chu
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 23 (07) : 927 - 936